MedPath
FDA Approval

GRANISETRON HYDROCHLORIDE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Wockhardt USA LLC.
DUNS: 170508365
Effective Date
November 28, 2019
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Granisetron(0.1 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Wockhardt USA LLC.

170508365

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Wockhardt Limited

Wockhardt USA LLC.

Wockhardt USA LLC.

676257570

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

GRANISETRON HYDROCHLORIDE

Product Details

NDC Product Code
64679-662
Application Number
ANDA078566
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
November 28, 2019
Code: 318F6L70J8Class: ACTIMQuantity: 0.1 mg in 1 mL
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath